Dr. Amir Ali Ghaffari, MD, PhD

Dr. Ghaffari practices at UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Dr. Ghaffari's NPI, 1588192181, was assigned on May 25, 2017. Dr. Ghaffari graduated from David Geffen School of Medicine at UCLA in 2016. Dr. Ghaffari holds Pennsylvania license MD479556.

Dr. Ghaffari's primary practice is UPMC Presbyterian, at 200 Lothrop Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 647-2345.

Dr. Ghaffari's primary practice is UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Ghaffari is also affiliated with Select Specialty Hospital - Pittsburgh / UPMC. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Ghaffari to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ghaffari practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Ghaffari's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Ghaffari is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Ghaffari's licenses on file in 2 states: Pennsylvania and California.

Dmand AI lists chronic inflammatory bowel disease (IBD), colonoscopy and upper GI endoscopy among the conditions Dr. Ghaffari treats.

CMS data shows 59 Medicare services from Dr. Ghaffari across 2 procedure codes in 2024, for 56 Medicare patients. Medicare paid $4,273 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 56 Medicare patients who saw Dr. Ghaffari in 2024. The largest group is 65 to 74, with 21 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ghaffari's median patient age at 46, with 47% women.

In 2024, Dr. Ghaffari wrote 189 Medicare Part D claims for 34 patients. 89% of them were for generic drugs. CMS names the drug for 125 of them, across 7 drugs with 11 or more claims each, at $11,690 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Ghaffari for performance year 2024, reported as part of a group. Dr. Ghaffari accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ghaffari as offering telehealth. CMS counts 12 procedures of colonoscopy by Dr. Ghaffari, more than 42% of the clinicians it reports for that procedure.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Ghaffari, published from 2010 to 2023. The most frequent topics are Signal Transduction, Interferon Type I and Antiviral Agents. Dr. Ghaffari's most frequent co-authors are David G. Binion, MD, Jane Chin Deng, MD and Anant Dhingra.

CMS Open Payments shows 5 general payments to Dr. Ghaffari from 5 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 90% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $123.

Dr. Ghaffari graduated from David Geffen School of Medicine at UCLA in 2016.

Dr. Ghaffari is in network with 8 carriers, including Aetna, Highmark and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.